Bell Investment Advisors, Inc

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1890149 ORINDA, CA

Position in RDY

as of Mar 31, 2026 · filed Apr 17, 2026 Compact

Position Value

$23,877

-$1,998 QoQ

Shares Held

1,724

-6.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bell Investment Advisors, Inc holds $125,074 across 19 Drug Manufacturers - Specialty & Generic names. RDY ranks #2 (19.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	41	$24,312
2	RDY	Dr Reddys Laboratories Ltd This page	1,724	$23,877
3	TAK	Takeda Pharmaceutical Co Ltd	905	$16,760
4	ZTS	Zoetis Inc.	83	$9,811
5	NBIX	Neurocrine Biosciences Inc	67	$8,826
6	ELAN	Elanco Animal Health Inc	288	$6,891
7	HLN	Haleon plc	660	$6,606
8	VTRS	Viatris Inc	466	$6,295

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$23,877	1,724	-6.5%	Shares	Sole	2026-04-17
2025-12-31	$25,875	1,843	+88.1%	Shares	Sole	2026-02-24
2025-09-30	$13,700	980	+5.9%	Shares	Sole	2025-11-21
2025-06-30	$13,902	925	+224.6%	Shares	Sole	2025-08-11
2025-03-31	$3,759	285	-56.0%	Shares	Sole	2025-05-16
2024-12-31	$10,216	647	+352.4%	Shares	Sole	2025-02-07
2024-09-30	$2,272	143	0.0%	Shares	Sole	2024-11-13
2024-06-30	$2,179	143	+18.2%	Shares	Sole	2024-08-08
2024-03-31	$1,775	121	+92.1%	Shares	Sole	2024-05-08
2023-12-31	$876	63	+12.5%	Shares	Sole	2024-02-14
2023-09-30	$748	56	+93.1%	Shares	Sole	2023-11-08
2023-06-30	$366	29	+190.0%	Shares	Sole	2023-08-09
2023-03-31	$113	10	-50.0%	Shares	Sole	2023-05-10
2022-12-31	$207	20	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.